278 related articles for article (PubMed ID: 23643347)
1. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes.
Sugisawa E; Miura J; Iwamoto Y; Uchigata Y
Diabetes Care; 2013 Aug; 36(8):2339-45. PubMed ID: 23579177
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
5. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
6. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
7. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
9. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence and complications of diabetes: does ethnic background or skin color matter?
Ahdi M; Gerdes VE; Graaff R; Kuipers S; Smit AJ; Meesters EW
Diabetes Technol Ther; 2015 Feb; 17(2):88-95. PubMed ID: 25562390
[TBL] [Abstract][Full Text] [Related]
11. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
12. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
14. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
16. Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.
Osawa S; Katakami N; Kuroda A; Takahara M; Sakamoto F; Kawamori D; Matsuoka T; Matsuhisa M; Shimomura I
J Atheroscler Thromb; 2017 Mar; 24(3):312-326. PubMed ID: 27592627
[TBL] [Abstract][Full Text] [Related]
17. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory.
Ducos C; Rigo M; Larroumet A; Delyfer MN; Korobelnik JF; Monlun M; Foussard N; Poupon P; Haissaguerre M; Blanco L; Mohammedi K; Rigalleau V
Diabetes Metab; 2021 Feb; 47(1):101156. PubMed ID: 32387701
[TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]